Standard curve
Example of Human GDF-15 standard curve in Assay Diluent #12YS2.
Product Details
Product Details
Product Specification
Antigen | GDF-15 |
Immunogen | Recombinant Protein |
Antibody Type | Recombinant mAb |
Reactivity | Hu |
Purification | Protein A |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8'C as supplied. |
Kit
Precision | Intra-assay: 2.1%; Inter-assay: 2.5% |
Sample type | Serum,Plasma |
Assay type | Sandwich (quantitative) |
Sensitivity | 0.484 pg/mL |
Range | 3.906 pg/mL – 250 pg/mL |
Recovery | Serum: 102% Plasma: 101% |
Assay time | 60 minutes |
Species reactivity | Hu |
Background
Human Growth Differentiation Factor 15 (GDF-15), also known as MIC-1 or PDF, is a stress-responsive cytokine belonging to the TGF-β superfamily. Primarily secreted by macrophages, epithelial cells, and placental tissues under pathological conditions, this 25-kDa dimeric protein signals through the glial cell-derived neurotrophic factor (GDNF) family receptor α-like (GFRAL)-RET complex in the brainstem. It regulates systemic energy homeostasis by suppressing appetite and modulating insulin sensitivity, while also functioning as a biomarker for cellular stress, cardiovascular disease, and cancer progression. Elevated GDF-15 levels correlate with cachexia, heart failure, and tumor metastasis, making it a therapeutic target for metabolic disorders and a diagnostic indicator for tissue damage. Its expression increases >100-fold during starvation, inflammation, and oxidative stress.
Picture
Picture
ELISA
Linearity
The concentrations of Human GDF-15 were measured and interpolated from the target standard curves and corrected for sample dilution.
The sample is undiluted samples are as follows: Human serum was 2fold dilution. The interpolated dilution factor corrected values are plotted. The mean target concentration was determined to be 431.79pg/mL in human serum.
The sample is undiluted samples are as follows: Human Plasma was 2fold dilution. The interpolated dilution factor corrected values are plotted. The mean target concentration was determined to be 323.97pg/mL in human plasma.
Leading Competitor comparison
